Incyte (INCY) Goodwill & Intangibles (2010 - 2026)
Incyte (INCY) reported Goodwill & Intangibles of $243.2 million for Q1 2026, down 7.61% on a YoY basis from $263.2 million in Q1 2025, and down 2.79% quarter-over-quarter from $250.1 million in Q4 2025.
Incyte (INCY) Goodwill & Intangibles (2010 - 2026) Analysis & Trends
Incyte has reported Goodwill & Intangibles for 17 years, with the latest figure at $243.2 million in Q1 2026.
- For the quarter ending Q1 2026, Goodwill & Intangibles fell 7.61% year-over-year to $243.2 million; the trailing twelve-month figure through Mar 2026 stood at $243.2 million (down 7.61% YoY), and the FY2025 full-year result was $250.1 million, down 7.15% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $243.2 million, down from $250.1 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $301.0 million in Q1 2022, with the low at $243.2 million in Q1 2026.
- Historically, Goodwill & Intangibles has averaged $277.8 million across 5 years, with a median of $279.1 million in 2023.
- Annual changes were most pronounced in 2024 — Goodwill & Intangibles dropped 7.7% — and 2025, when it grew 4.79%.
- Incyte's Goodwill & Intangibles stood at $284.8 million in 2022, then decreased by 1.99% to $279.1 million in 2023, then dropped by 3.49% to $269.4 million in 2024, then slipped by 7.15% to $250.1 million in 2025, then slipped by 2.79% to $243.2 million in 2026.
- The last three Goodwill & Intangibles figures came in at $243.2 million (Q1 2026), $250.1 million (Q4 2025), and $275.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 243.16 Mn |
| Dec 31, 2025 | 250.13 Mn |
| Sep 30, 2025 | 275.01 Mn |
| Jun 30, 2025 | 282.01 Mn |
| Mar 31, 2025 | 263.20 Mn |
| Dec 31, 2024 | 269.40 Mn |
| Sep 30, 2024 | 275.59 Mn |
| Jun 30, 2024 | 269.13 Mn |
| Mar 31, 2024 | 273.43 Mn |
| Dec 31, 2023 | 279.14 Mn |
| Sep 30, 2023 | 284.84 Mn |
| Jun 30, 2023 | 290.55 Mn |
| Mar 31, 2023 | 296.25 Mn |
| Dec 31, 2022 | 284.81 Mn |
| Sep 30, 2022 | 290.20 Mn |
| Jun 30, 2022 | 295.58 Mn |
| Mar 31, 2022 | 300.96 Mn |
| Dec 31, 2021 | 306.35 Mn |
| Sep 30, 2021 | 311.73 Mn |
| Jun 30, 2021 | 317.12 Mn |